Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

20 results
Display

Anhedonia and Depressive Disorders

Serretti A

  • KMID: 2545801
  • Clin Psychopharmacol Neurosci.
  • 2023 Aug;21(3):401-409.
  • doi: 10.9758/cpn.23.1086
Anhedonia is a core symptom of depression and of several psychiatric disorders. Anhedonia has however expanded from its original definition to encompass a spectrum of reward processing deficits that received...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Potential Effect of Vortioxetine on Restless Leg Syndrome

Alıcı YH, Kumcu MK

  • KMID: 2545819
  • Clin Psychopharmacol Neurosci.
  • 2023 Aug;21(3):599-603.
  • doi: 10.9758/cpn.22.1021
Restless legs syndrome (RLS) is a chronic progressive movement disorder characterized by abnormal sensations, especially at rest and at night, as the need and urge to move the lower extremity....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Link between Suicidality and Electroencephalography Asymmetry: A Systematic Review and Meta-analysis

Butler LB, Nooner KB

  • KMID: 2545803
  • Clin Psychopharmacol Neurosci.
  • 2023 Aug;21(3):419-428.
  • doi: 10.9758/cpn.22.1043
As one of the leading causes of death globally, suicide has been researched extensively to better understand factors that confer risk or resilience for suicidality. Promising areas of the literature...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Successful Early Lamotrigine and Aripiprazole Augmentation of Clomipramine in Severe Obsessive-compulsive Disorder

Seo EH, Kim SG, Lee JH, Yoon HJ

  • KMID: 2545820
  • Clin Psychopharmacol Neurosci.
  • 2023 Aug;21(3):604-608.
  • doi: 10.9758/cpn.22.1044
Lamotrigine and aripiprazole have shown efficacy as augmentation agents of serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder (OCD). To date, the efficacy of lamotrigine/aripiprazole augmentation has not been reported in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Oxytocin Levels in Children with Separation Anxiety and Their Mothers before and after Treatment

Üstün NSG, Gümüş , Soylu N

  • KMID: 2545810
  • Clin Psychopharmacol Neurosci.
  • 2023 Aug;21(3):499-515.
  • doi: 10.9758/cpn.22.1008
Objective: The purpose of this study was to compare the plasma oxytocin levels of children with separation anxiety disorder (SAD) and their mothers with those of healthy controls and to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Does Post-traumatic Stress Disorder Impact Treatment Outcomes within a Randomised Controlled Trial of Mitochondrial Agents for Bipolar Depression?

Russell SE, Wrobel AL, Ashton MM, Turner A, Mohebbi M, Berk M, Cotton S, Dodd S, Ng CH, Malhi GS, Dean OM

  • KMID: 2545806
  • Clin Psychopharmacol Neurosci.
  • 2023 Aug;21(3):457-465.
  • doi: 10.9758/cpn.22.981
Objective: Bipolar disorder often co-occurs with post-traumatic stress disorder, yet few studies have investigated the impact of post-traumatic stress disorder in bipolar disorder on treatment outcomes. The aim of this...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting

Lee KH, Han TS, Han C, Bahk WM, Lee SJ, Patkar AA, Masand PS, Pae CU

  • KMID: 2545818
  • Clin Psychopharmacol Neurosci.
  • 2023 Aug;21(3):594-598.
  • doi: 10.9758/cpn.23.1060
Objective: This study tried to observe additional benefit of agomelatine (AGO) treatment for major depressive disorder (MDD) in routine practice. Methods: Retrospective chart review (n = 63) was conducted for additional...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Role of Glutamate Underlying Treatment-resistant Depression

Kim J, Kim TE, Lee SH, Koo JW

  • KMID: 2545804
  • Clin Psychopharmacol Neurosci.
  • 2023 Aug;21(3):429-446.
  • doi: 10.9758/cpn.22.1034
The monoamine hypothesis has significantly improved our understanding of mood disorders and their treatment by linking monoaminergic abnormalities to the pathophysiology of mood disorders. Even 50 years after the monoamine...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Drug-drug Interaction between Psychotropic Medications and Medications Used in COVID-19: Comparison of Online Databases

Chatterjee S, Kar SK, Prakash AJ, Bansal T, Singh G

  • KMID: 2545813
  • Clin Psychopharmacol Neurosci.
  • 2023 Aug;21(3):534-543.
  • doi: 10.9758/cpn.22.1014
Objective: COVID-19 has gravely affected patients with psychiatric conditions. Potential interactions may occur between psychotropic medications and medications used in treatment of COVID-19. This study aimed to compare the online...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Oxidative Stress and Inflammatory Biomarkers in People with Methamphetamine Use Disorder

Turan , enormanci G, Neşelioğlu S, Budak Y, Erel , Şenormancı

  • KMID: 2545816
  • Clin Psychopharmacol Neurosci.
  • 2023 Aug;21(3):572-582.
  • doi: 10.9758/cpn.22.1047
Objective: This study aimed to investigate the blood serum levels of biomarkers specifying oxidative stress status and systemic inflammation between people using methamphetamine (METH) and the control group (CG). Serum...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Development of a Guideline for Antipsychotic-induced Hyperprolactinemia in Korea Using the ADAPTE Process

Kim HR, Kim SM, Kang WS, Jeon HJ, Jang SH, Jon DI, Hong J, Jeong JH

  • KMID: 2545805
  • Clin Psychopharmacol Neurosci.
  • 2023 Aug;21(3):447-456.
  • doi: 10.9758/cpn.22.979
Objective: To develop an evidence-based guideline for the diagnosis and treatment of antipsychotic-induced hyperprolactinemia by adapting existing high-quality clinical guidelines with a view to improve the clinical symptoms and long-term...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Randomized Clinical Trial to Assess the Effect of Medication Therapy Plus tDCS on Problem-solving and Emotion Regulation of Patients with Bipolar Disorder Type I

Mardani P, Javdani H, Zolghadriha A, Mousavi SE, Dadashi M

  • KMID: 2545807
  • Clin Psychopharmacol Neurosci.
  • 2023 Aug;21(3):466-477.
  • doi: 10.9758/cpn.22.988
Objective: This study aims to evaluate the effectiveness of medication therapy combined with transcranial Direct Current Stimulation (tDCS) in improving problem-solving and emotion regulation abilities of patients with bipolar disorder...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Outcome of Antipsychotics-induced Tardive Syndromes: A Ten-year Follow-up Study

Chou PC, Lee Y, Chang YY, Lin PY, Wang LJ

  • KMID: 2545809
  • Clin Psychopharmacol Neurosci.
  • 2023 Aug;21(3):488-498.
  • doi: 10.9758/cpn.22.1000
Objective: Tardive syndrome (TS) is an umbrella term used to describe a group of abnormal movement disorders caused by chronic exposure to dopamine receptor blocking agents. Few follow-up studies have...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Implication of Maumgyeol Basic Service–the 2 Channel Electroencephalography and a Photoplethysmogram–based Mental Health Evaluation Software

Lee SH, Hwang HH, Kim S, Hwang J, Park J, Park S

  • KMID: 2545817
  • Clin Psychopharmacol Neurosci.
  • 2023 Aug;21(3):583-593.
  • doi: 10.9758/cpn.23.1062
Objective: Maumgyeol Basic service is a mental health evaluation and grade scoring software using the 2 channels EEG and photoplethysmogram (PPG). This service is supposed to assess potential at-risk groups...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Impact of COVID-19 on Psychiatric Health in the Korean Population

Wang SM, Kim SH, Choi WS, Lim HK, Woo YS, Pae CU, Bahk WM

  • KMID: 2545802
  • Clin Psychopharmacol Neurosci.
  • 2023 Aug;21(3):410-418.
  • doi: 10.9758/cpn.23.1083
Coronavirus disease 2019 (COVID-19) has multiple negative impacts on the psychiatric health of both those previously infected and not infected with severe acute respiratory syndrome coronavirus 2. Moreover, the negative...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Arterial Stiffness in Patients with Bipolar Disorder

Kılıçaslan AK, Emir BS, Yıldız S, Kılıçaslan G, Kurt O

  • KMID: 2545811
  • Clin Psychopharmacol Neurosci.
  • 2023 Aug;21(3):516-525.
  • doi: 10.9758/cpn.22.1009
Objective: Bipolar disorder (BD) is an inflammatory and metabolic disease. The disease and the drugs used to treat it may affect cardiovascular disease (CVD) risk. The aim of this study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Evaluation of Atherosclerotic Risk by Oxidative Contributors in Alcohol Use Disorder

Senat A, Kabadayi-Sahin E, Sogut I, Duymaz T, Erel O

  • KMID: 2545812
  • Clin Psychopharmacol Neurosci.
  • 2023 Aug;21(3):526-533.
  • doi: 10.9758/cpn.22.1010
Objective: Alcohol Use Disorder (AUD) is a condition described as the inability to control or stop alcohol consumption. The patients with AUD have an increased risk of developing atherosclerosis-related diseases. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Which Severe Mental Illnesses Most Increase the Risk of Developing Dementia? Comparing the Risk of Dementia in Patients with Schizophrenia, Major Depressive Disorder and Bipolar Disorder

Chang WH, Su CC, Chen KC, Hsiao YY, Chen PS, Yang YK

  • KMID: 2545808
  • Clin Psychopharmacol Neurosci.
  • 2023 Aug;21(3):478-487.
  • doi: 10.9758/cpn.22.991
Objective: Previous studies have shown that certain severe mental illnesses (SMIs) increase the risk of dementia, but those that increase the risk to a greater degree in comparison with other...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Parental Verbal Abuse Experience on the Glutamate Response to Swear Words in the Ventromedial Prefrontal Cortex: A Functional 1 H-magnetic Resonance Spectroscopy Study

Yoo JH, Park YW, Kim D, Park H, Jeong B

  • KMID: 2545815
  • Clin Psychopharmacol Neurosci.
  • 2023 Aug;21(3):559-571.
  • doi: 10.9758/cpn.22.1019
Objective: Several lines of evidence indicate verbal abuse (VA) critically impacts the developing brain; however, whether VA results in changes in brain neurochemistry has not been established. Here, we hypothesized...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment Retention Rates of 3-monthly Paliperidone Palmitate and Risk Factors Associated with Discontinuation: A Population-based Cohort Study

Lin CH, Lin HL, Chiang CL, Chen YW, Liu YF, Yang YK, Tang CH

  • KMID: 2545814
  • Clin Psychopharmacol Neurosci.
  • 2023 Aug;21(3):544-558.
  • doi: 10.9758/cpn.22.1017
Objective: Limited evidence exists regarding real-world 3-monthly paliperidone palmitate (PP3M) treatment retention and associated factors. Methods: We conducted a retrospective, nationwide cohort study using the Taiwan National Health Insurance Research Database...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr